Wednesday, February 18, 2015

Syneron Medical's (ELOS) CEO Amit Meridor on Q4 2014 Results - Earnings Call Transcript (ELOS)

We expanded gross margin to 55.7% due to positive product and .... new team is changing the focus of Iluminage Beauty product and distribution mix.


Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)